Interest Expense in USD of ELITE PHARMACEUTICALS INC /NV/ from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly/annual Interest Expense history and change rate from Q2 2010 to Q1 2024.
  • ELITE PHARMACEUTICALS INC /NV/ Interest Expense for the quarter ending 31 Mar 2024 was $217,144.000, a 34.3% decline year-over-year.
  • ELITE PHARMACEUTICALS INC /NV/ Interest Expense for the twelve months ending 31 Mar 2024 was $588,622.000, a 47.1% decline year-over-year.
  • ELITE PHARMACEUTICALS INC /NV/ annual Interest Expense for 2023 was $588,622.000, a 47.1% decline from 2022.
  • ELITE PHARMACEUTICALS INC /NV/ annual Interest Expense for 2022 was $1,112,707.000, a 480% increase from 2021.
  • ELITE PHARMACEUTICALS INC /NV/ annual Interest Expense for 2021 was $191,816.000, a 26.1% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $588,622 $217,144 -$113,342 -34.3% 01 Jan 2024 31 Mar 2024 10-K 01 Jul 2024
Q4 2023 $701,964 $121,628 -$201,053 -62.3% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2024
Q3 2023 $903,017 $130,438 -$112,315 -46.3% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $1,015,332 $119,412 -$97,375 -44.9% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $1,112,707 $330,486 +$265,046 +4.1% 01 Jan 2023 31 Mar 2023 10-K 01 Jul 2024
Q4 2022 $847,661 $322,681 +$285,281 +7.6% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024
Q3 2022 $562,380 $242,753 +$199,670 +4.6% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $362,710 $216,787 +$170,894 +3.7% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $191,816 $65,440 +$44,699 +2.2% 01 Jan 2022 31 Mar 2022 10-K 29 Jun 2023
Q4 2021 $147,117 $37,400 -$42,273 -53.1% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023
Q3 2021 $189,390 $43,083 -$36,670 -46% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $226,060 $45,893 -$33,538 -42.2% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $259,598 $20,741 -$51,484 -71.3% 01 Jan 2021 31 Mar 2021 10-K 29 Jun 2022
Q4 2020 $311,082 $79,673 -$14,841 -15.7% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022
Q3 2020 $325,923 $79,753 -$11,712 -12.8% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $337,635 $79,431 -$18,239 -18.7% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 $355,874 $72,225 -$17,911 -19.9% 01 Jan 2020 31 Mar 2020 10-K 14 Jun 2021
Q4 2019 $373,785 $94,514 +$4,617 +5.1% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021
Q3 2019 $369,168 $91,465 -$14,537 -13.7% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $383,705 $97,670 +$14,532 +17.5% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 $369,173 $90,136 +$368 +0.41% 01 Jan 2019 31 Mar 2019 10-K 29 Jun 2020
Q4 2018 $368,805 $89,897 -$2,561 -2.8% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020
Q3 2018 $371,366 $106,002 +$23,461 +28.4% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $347,905 $83,138 +$12,407 +17.5% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 $335,498 $89,768 +$33,428 +59.3% 01 Jan 2018 31 Mar 2018 10-K 21 Jun 2019
Q4 2017 $302,070 $92,458 +$36,895 +66.4% 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019
Q3 2017 $265,175 $82,541 +$25,164 +43.9% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 $240,011 $70,731 +$1,788 +2.6% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $238,223 $56,340 -$16,159 -22.3% 01 Jan 2017 31 Mar 2017 10-K 14 Jun 2018
Q4 2016 $254,382 $55,563 -$12,556 -18.4% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018
Q3 2016 $266,938 $57,377 -$6,447 -10.1% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $273,385 $68,943 -$7,285 -9.6% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017
Q1 2016 $280,670 $72,499 -$299 -0.41% 01 Jan 2016 31 Mar 2016 10-K 14 Jun 2018
Q4 2015 $280,969 $68,119 +$1,966 +3% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017
Q3 2015 $279,003 $63,824 -$6,251 -8.9% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 $285,254 $76,228 -$1,977 -2.5% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 $287,231 $72,798 -$96,677 -57% 01 Jan 2015 31 Mar 2015 10-K 14 Jun 2017
Q4 2014 $383,908 $66,153 -$292,977 -81.6% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016
Q3 2014 $676,885 $70,075 -$185,870 -72.6% 01 Jul 2014 30 Sep 2014 10-Q 30 Dec 2015
Q2 2014 $862,755 $78,205 +$3,427 +4.6% 01 Apr 2014 30 Jun 2014 10-Q 30 Dec 2015
Q1 2014 $859,328 $169,475 +$99,440 +1.4% 01 Jan 2014 31 Mar 2014 10-K 15 Jun 2016
Q4 2013 $759,888 $359,130 +$295,206 +4.6% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 $464,682 $255,945 +$194,698 +3.2% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 $269,984 $74,778 +$16,239 +27.7% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 $253,745 $70,035 +$12,882 +22.5% 01 Jan 2013 31 Mar 2013 10-K 30 Jun 2014
Q4 2012 $240,863 $63,924 +$6,786 +11.9% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014
Q3 2012 $234,077 $61,247 +$3,316 +5.7% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 $230,761 $58,539 +$1,169 +2% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 $229,592 $57,153 -$116,865 -67.2% 01 Jan 2012 31 Mar 2012 10-K 21 Jun 2013
Q4 2011 $346,457 $57,138 -$921 -1.6% 01 Oct 2011 31 Dec 2011 10-Q 14 Feb 2013
Q3 2011 $347,378 $57,931 +$194 +0.34% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 $347,184 $57,370 +$115,439 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012
Q1 2011 $231,745 $174,018 01 Jan 2011 31 Mar 2011 10-K 29 Jun 2012
Q4 2010 $58,059 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012
Q3 2010 $57,737 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$58,069 01 Apr 2010 30 Jun 2010 10-Q/A 19 Aug 2011

ELITE PHARMACEUTICALS INC /NV/ Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $588,622 -$524,085 -47.1% 01 Apr 2023 31 Mar 2024 10-K 01 Jul 2024
2022 $1,112,707 +$920,891 +4.8% 01 Apr 2022 31 Mar 2023 10-K 01 Jul 2024
2021 $191,816 -$67,782 -26.1% 01 Apr 2021 31 Mar 2022 10-K 29 Jun 2023
2020 $259,598 -$96,276 -27.1% 01 Apr 2020 31 Mar 2021 10-K 29 Jun 2022
2019 $355,874 -$13,299 -3.6% 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021
2018 $369,173 +$33,675 +10% 01 Apr 2018 31 Mar 2019 10-K 29 Jun 2020
2017 $335,498 +$97,275 +40.8% 01 Apr 2017 31 Mar 2018 10-K 21 Jun 2019
2016 $238,223 -$42,447 -15.1% 01 Apr 2016 31 Mar 2017 10-K 14 Jun 2018
2015 $280,670 -$6,561 -2.3% 01 Apr 2015 31 Mar 2016 10-K 14 Jun 2018
2014 $287,231 -$572,097 -66.6% 01 Apr 2014 31 Mar 2015 10-K 14 Jun 2017
2013 $859,328 +$605,583 +2.4% 01 Apr 2013 31 Mar 2014 10-K 15 Jun 2016
2012 $253,745 +$24,153 +10.5% 01 Apr 2012 31 Mar 2013 10-K 30 Jun 2014
2011 $229,592 -$2,153 -0.93% 01 Apr 2011 31 Mar 2012 10-K 21 Jun 2013
2010 $231,745 01 Apr 2010 31 Mar 2011 10-K 29 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.